News_第8页_Shenyang Dasan Pharmaceutical Technology Co., Ltd.

Home


Distinguish	Title	Data
Industry	NMPA Seeks Public Comments on Proposed Further Strengthening of MAH Contract Manufacturing Supervision	2023-05-26
Company	Causes and Solutions for Overloading of Reversed-Phase Columns	2023-05-19
Company	Bask in the warm sun and cherish the moment.	2023-05-12
Industry	Tasly: 21 Exclusive Products Hit RMB 8.5 Billion, Bags Two First-to-Market Generics	2023-04-28
Industry	Haisco Exclusive Product Up 4,211% \| 13 Class 1 New Drugs Advancing	2023-04-21
Industry	Price, Reimbursement Cuts Coming for Non-Selected Drugs in Procurement	2023-04-14
Industry	8th Round Centralized Procurement: 6 Varieties Included in Local Monitoring Catalog! Tianjin Adds 13	2023-04-07
Industry	8th Round Centralized Procurement: Summary of Price Cuts, Selection Rate & Winning Varieties	2023-03-31
Industry	Top 10 Sales in Beijing, Shanghai, Guangzhou! Star Drug Up 150%, Anti-Cancer Drugs Dominate	2023-03-24
Industry	Big Alliance Drug Procurement Results Out! Billion-Yuan Market Reshuffled.	2023-03-17
Company	Happy Women’s Day to all the goddesses!	2023-03-08
Company	Unite for a New Chapter · High-Quality Development	2023-03-07